These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 11769675

  • 1. [Detection of -5/5q- chromosome abnormality in myelodysplastic syndromes by interphase fluorescence in situ hybridization].
    Shen Y, Xue Y, Li J.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):517-9. PubMed ID: 11769675
    [Abstract] [Full Text] [Related]

  • 2. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M, Arenillas L, Espinet B, Salido M, Hernández JM, Lumbreras E, del Rey M, Arranz E, Ramiro S, Font P, González O, Renedo M, Cervera J, Such E, Sanz GF, Luño E, Sanzo C, González M, Calasanz MJ, Mayans J, García-Ballesteros C, Amigo V, Collado R, Oliver I, Carbonell F, Bureo E, Insunza A, Yañez L, Muruzabal MJ, Gómez-Beltrán E, Andreu R, León P, Gómez V, Sanz A, Casasola N, Moreno E, Alegre A, Martín ML, Pedro C, Serrano S, Florensa L, Solé F.
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [Abstract] [Full Text] [Related]

  • 3. [Detection of monosomy 7 or 7q- in cases of myelodysplastic syndrome].
    Shen Y, Xue Y, Li J, Guo Y, Pan J, Wu Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):255-8. PubMed ID: 11484160
    [Abstract] [Full Text] [Related]

  • 4. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
    Bigoni R, Cuneo A, Milani R, Cavazzini F, Bardi A, Roberti MG, Agostini P, della Porta M, Specchia G, Rigolin GM, Castoldi G.
    Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
    [Abstract] [Full Text] [Related]

  • 5. [Detection of trisomy 8 with interphase fluorescence in situ hybridization in myelodysplastic syndromes].
    Li J, Pan J, Xue Y, Wu C, Xie X, Guo Y, Ruan C.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):179-81. PubMed ID: 11876976
    [Abstract] [Full Text] [Related]

  • 6. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
    Chen L, Li J, Zhu Y, Qiu H, Pan J, Wang R, Qian S, Xu W, Xue Y.
    Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
    [Abstract] [Full Text] [Related]

  • 7. [Detection of common chromosome abnormalities in myelodysplastic syndrome with a panel fluorescence in situ hybridization].
    Shen Y, Xue Y, Li J, Pan J, Wu Y, Chen S.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):160-3. PubMed ID: 12673589
    [Abstract] [Full Text] [Related]

  • 8. Interphase FISH does not improve the detection of DEL(5q) and DEL(20q) in myelodysplastic syndromes.
    Douet-Guilbert N, Herry A, LE Bris MJ, Guéganic N, Bovo C, Morel F, DE Braekeleer M.
    Anticancer Res; 2011 Mar; 31(3):1007-10. PubMed ID: 21498729
    [Abstract] [Full Text] [Related]

  • 9. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
    Beyer V, Castagné C, Mühlematter D, Parlier V, Gmür J, Hess U, Kovacsovics T, Meyer-Monard S, Tichelli A, Tobler A, Jacky E, Schanz U, Bargetzi M, Hagemeijer A, de Witte T, van Melle G, Jotterand M.
    Cancer Genet Cytogenet; 2004 Jul 01; 152(1):29-41. PubMed ID: 15193439
    [Abstract] [Full Text] [Related]

  • 10. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
    Pitchford CW, Hettinga AC, Reichard KK.
    Am J Clin Pathol; 2010 Feb 01; 133(2):260-4. PubMed ID: 20093235
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
    Chen LJ, Li JY, Xiao B, Zhu Y, Liu Q, Pan JL, Qiu HR, Fan L, Zhang SJ, Lu RN, Xu W, Xue YQ.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec 01; 24(6):635-9. PubMed ID: 18067073
    [Abstract] [Full Text] [Related]

  • 12. [Detection of cytogenetic abnormalities involving chromosomes 5,7 and 8 in myelodysplastic syndromes with fluorescence in situ hybridization and its clinical significance].
    Cai Y, Qin YW, Wang C, Yang J, Yan SK.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan 01; 28(1):6-10. PubMed ID: 17649717
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.
    Evers C, Beier M, Poelitz A, Hildebrandt B, Servan K, Drechsler M, Germing U, Royer HD, Royer-Pokora B.
    Genes Chromosomes Cancer; 2007 Dec 01; 46(12):1119-28. PubMed ID: 17823930
    [Abstract] [Full Text] [Related]

  • 15. Clinical relevance of cytogenetics in myelodysplastic syndromes.
    Bernasconi P, Boni M, Cavigliano PM, Calatroni S, Giardini I, Rocca B, Zappatore R, Dambruoso I, Caresana M.
    Ann N Y Acad Sci; 2006 Nov 01; 1089():395-410. PubMed ID: 17261783
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of monosomy 7 by fluorescence in situ hybridization in acute nonlymphocytic leukemia and myelodysplastic syndrome.
    Nakagawa H.
    Jpn J Hum Genet; 1993 Sep 01; 38(3):257-66. PubMed ID: 8260718
    [Abstract] [Full Text] [Related]

  • 18. Submicroscopic deletions in 5q- associated malignancies.
    Crescenzi B, La Starza R, Romoli S, Beacci D, Matteucci C, Barba G, Aventin A, Marynen P, Ciolli S, Nozzoli C, Martelli MF, Mecucci C.
    Haematologica; 2004 Mar 01; 89(3):281-5. PubMed ID: 15020265
    [Abstract] [Full Text] [Related]

  • 19. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients.
    Yilmaz Z, Sahin FI, Kizilkilic E, Karakus S, Boga C, Ozdogu H.
    Clin Exp Med; 2005 Jul 01; 5(2):55-9. PubMed ID: 16096854
    [Abstract] [Full Text] [Related]

  • 20. [Multiplex fluorescence in situ hybridization in detecting complex chromosomal aberrations in myelodysplastic syndromes].
    Xiao B, Li JY, Pan JL, Ma L, Qiu HR, Wu YF, Xue YQ.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep 01; 26(9):513-6. PubMed ID: 16468325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.